CFDA Ups Scrutiny of Medical Devices to Promote Safety

The CFDA has begun a five-month campaign to root out unsafe medical products in China. The effort will target a wide range of possible problems, ranging from counterfeit products, to medical equipment that is not sterile, to websites promoting useless products, to complex medical devices whose clinical trial data may have been compromised. The increased oversight is a precursor to more thorough regulatory reform. Soon, China’s State Council will issue a revision of the Regulations on Medical Instrument Management, which will put new long-term rules in place for monitoring the safety of medical devices. More details.... Share this with colleagues: // //